BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home
»
Newsletters
» BioWorld
BioWorld
March 14, 2003
View Archived Issues
Streptococcus Pneumoniae Will Thumb Nose At Top Antibiotics Penicillin, Erythromycin In 2004
Read More
Boston Life Sciences Raises $10M In Private Placement
Read More
With Shareholders In Mind, SignalGene To Close Doors
Read More
Correction
Read More
Other News To Note
Read More
Challenges Of Confirmatory Trials Subject Of FDA Panel
After a decade of clearing certain oncology drugs under accelerated approval guidelines, the FDA is asking companies to explain why it takes so long to successfully complete confirmatory efficacy studies. (BioWorld Today)
Read More
Cytokine PharmaSciences Signs Baxter To MIF Technology Deal
Read More
